Atlas Trials

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome

Clinical trial NCT01104415 · COMPLETED

Trial details

NCT number
NCT01104415
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoid Syndrome
Start date
2010-06-15
Primary completion
2014-02-12
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.